Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stanford

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunobiology|October 1, 1994
Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659J L Stanford, C A Stanford
Society for Applied Bacteriology Symposium Series|January 1, 1996
Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosisJ L Stanford, C A Stanford
Psychological Reports|June 1, 1983
Gender, grade point average, and test anxietyJ B Best, C A Stanford
Science Progress|August 30, 2001
Environmental echoesJ L Stanford, C A Stanford, J M Grange
Vaccine|July 16, 2008
The use of mycobacterial adjuvant-based agents for immunotherapy of cancerJ M Grange, O Bottasso, C A Stanford, et al.
Respiratory Medicine|January 1, 1997
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary diseaseE Corlan, C Marica, C Macavei, et al.
Respiratory Medicine|January 1, 1997
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed diseaseE Corlan, C Marica, C Macavei, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2007
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lungJ L Stanford, C A Stanford, M E R O'Brien, et al.
Respiratory Medicine|June 26, 2001
Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?J L Stanford, C A Stanford, J M Grange, et al.
Respiratory Medicine|July 1, 1993
Chemoprophylaxis for tuberculosisJ L Stanford, C A Stanford, G A Rook, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunobiology|October 1, 1994
Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659J L Stanford, C A Stanford
Society for Applied Bacteriology Symposium Series|January 1, 1996
Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosisJ L Stanford, C A Stanford
Psychological Reports|June 1, 1983
Gender, grade point average, and test anxietyJ B Best, C A Stanford
Science Progress|August 30, 2001
Environmental echoesJ L Stanford, C A Stanford, J M Grange
Vaccine|July 16, 2008
The use of mycobacterial adjuvant-based agents for immunotherapy of cancerJ M Grange, O Bottasso, C A Stanford, et al.
Respiratory Medicine|January 1, 1997
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary diseaseE Corlan, C Marica, C Macavei, et al.
Respiratory Medicine|January 1, 1997
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed diseaseE Corlan, C Marica, C Macavei, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2007
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lungJ L Stanford, C A Stanford, M E R O'Brien, et al.
Respiratory Medicine|June 26, 2001
Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?J L Stanford, C A Stanford, J M Grange, et al.
Respiratory Medicine|July 1, 1993
Chemoprophylaxis for tuberculosisJ L Stanford, C A Stanford, G A Rook, et al.
Pageof 2